MedTrace Logo

Denver Health Cardiovascular Disease (CVD) Prevention Program

NCT00829491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2012-07-17

No results posted yet for this study

Summary

The objective of the Denver Health CVD Prevention Program is to assess the effectiveness of developing an enhanced cardiovascular disease prevention program in a community health care setting.

Conditions

Interventions

BEHAVIORAL

CVD risk reduction program

Participants will be selected through review of the DH administrative databases or by referral from their primary care provider. After completion of the forms, the navigator and client will discuss potential CVD risk reduction activities and programs available through this program for the client to participate in. Potential activities will include self-monitoring using self-help tools,healthy nutrition and exercise activities, community-based exercise programs using the recreation centers in the community, and referral to the Colorado Quitline for smoking cessation activities. Follow-up questionnaires will be completed at 6 and 12 months after enrollment to assess changes in levels of exercise, dietary patterns, and beliefs and attitudes about behavioral change.

Sponsors & Collaborators

  • Colorado Department of Public Health and Environment

    collaborator OTHER_GOV

  • Denver Health and Hospital Authority

    lead OTHER

Principal Investigators

  • Judith Shlay, MD, MSPH · Denver Health and Hospital Authority

  • Christopher Urbina, MD, MPH · Denver Health and Hospital Authority

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00829491 on ClinicalTrials.gov